Forget the legends. An old-fashioned arrow to the heart is all you need to slay a vampire -- especially if said vampire sports perfect hair and a sculpted teenage body.
Arrow, the DC Comics adaptation Time Warner (NYSE: TWX ) introduced in October, now ranks as the CW network's top rated show, beating the Twilight-inspired The Vampire Diaries. More than 3 million viewers on average tune in weekly to see Stephen Amell's avenging archer, Nielsen reports, versus 2.8 million for the bloodsuckers.
Surprised? You shouldn't be, says Tim Beyers of Motley Fool Rule Breakers and Motley Fool Supernova in the following video. AMC Networks' (NASDAQ: AMCX ) top-rated drama The Walking Dead is inspired by a comic book of the same name, and Walt Disney (NYSE: DIS ) is preparing to launch Iron Man 3 in the U.S �on May 3. All signs suggest that the film will be one of the summer season's biggest.
Do you enjoy Arrow? How much TV do you consume daily? Please watch this short video to get Tim's full take, and then leave a comment to let us know what you think of the show and whether you'd buy, sell, or short Time Warner stock at current prices.
Hot Net Payout Yield Stocks To Own Right Now: Varian Medical Systems Inc.(VAR)
Varian Medical Systems, Inc. designs, manufactures, sells, and services equipment and software products for treating cancer with radiotherapy, stereotactic radiotherapy, stereotactic body radiotherapy, stereotactic radiosurgery, and brachytherapy worldwide. Its Oncology Systems segment offers products, such as linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment, and accessories; and information management, treatment planning, and image processing software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, doctors? offices, and cancer care clinics. The company?s X-ray Products segment provides x-ray tubes for use in a range of applications, including computed tomography scanning, radiographic or fluoroscopic imaging, mammography, special procedures, and industrial applications; and flat panel digital image detectors for filmless x-ray imaging. It sells t hese products to imaging systems original equipment manufacturers that incorporate them into their medical diagnostic, dental, veterinary, and industrial imaging systems; independent service companies; and directly to end-users. The company also designs, manufactures, sells, and services Linatron x-ray accelerators, imaging processing software, and image detection products for security and inspection purposes, such as cargo screening at ports and borders, and nondestructive examination in various applications. In addition, it develops products and systems for delivering proton therapy; and technologies in the areas of digital X-ray imaging technology, volumetric and functional imaging, improved X-ray sources, and technology for security and cargo screening applications. The company was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. Varian Medical Systems, Inc. was founded in 1948 and is headquartered in Palo Alto , California.
Advisors' Opinion:- [By Monica Gerson]
Varian Medical Systems (NYSE: VAR) is projected to post its Q4 earnings at $1.12 per share on revenue of $779.02 million.
Thermo Fisher Scientific (NYSE: TMO) is estimated to report its Q3 earnings at $1.28 per share on revenue of $3.18 billion.
- [By Ben Levisohn]
Intuitive Surgical has fallen 4.4% to $381.39 today, but doesn’t seem to be having much of an impact on comparable companies. Hologic (HOLX) has ticked up 0.2% to $22.06, Danaher (DHR) has fallen -.4% to $72.05 and Varian Medical Systems (VAR) has gained 0.2% to $78.70.
- [By Seth Jayson]
Basic guidelines
In this series, I examine inventory using a simple rule of thumb: Inventory increases ought to roughly parallel revenue increases. If inventory bloats more quickly than sales grow, this might be a sign that expected sales haven't materialized. Is the current inventory situation at Varian Medical Systems (NYSE: VAR ) out of line? To figure that out, start by comparing the company's inventory growth to sales growth. How is Varian Medical Systems doing by this quick checkup? At first glance, not so great. Trailing-12-month revenue increased 7.2%, and inventory increased 13.0%. Comparing the latest quarter to the prior-year quarter, the story looks decent. Revenue grew 6.7%, and inventory increased 13.0%. Over the sequential quarterly period, the trend looks healthy. Revenue grew 13.3%, and inventory grew 0.6%.
Top 5 Stocks To Invest In 2014: TFS Financial Corporation(TFSL)
TFS Financial Corporation operates as a holding company for Third Federal Savings and Loan Association of Cleveland. The company provides retail consumer banking, including mortgage lending, deposit gathering, and other financial services in Ohio and Florida. Its deposit accounts consist of savings accounts, negotiable order of withdrawal accounts, certificates of deposit accounts, individual retirement accounts, and other qualified plan accounts. The company also offers residential real estate mortgage loans, home equity loans, lines of credit, residential construction loans, and consumer loans. It operates 39 full-service branches and 8 loan production offices. TFS Financial Corporation, through its subsidiary, Third Capital, Inc. engages in net lease transactions of commercial buildings; maintains minority investments in private equity funds, and provide escrow and settlement services; and reinsures private mortgage insurance on residential mortgage loans. The company w as founded in 1938 and is headquartered in Cleveland, Ohio.
Advisors' Opinion:- [By Jim Royal]
The special situation
For those of you following my Special Situations portfolio, Investors Bancorp is in a spot similar to First Financial Northwest (NASDAQ: FFNW ) and TFS Financial (NASDAQ: TFSL ) , both of which are featured substantially in the portfolio. While Investors Bancorp is still only a partially demutualized thrift (like TFS Financial today), it will soon become a fully public institution, like First Financial.
Top 5 Stocks To Invest In 2014: Capital Bank Financial Corp (CBF)
Capital Bank Financial Corp, formerly North American Financial Holdings, Inc., incorporated in 2009, is a bank holding Company. The Company focuses on creating a regional banking franchise in the southeastern region of the United States through organic growth and acquisitions of other banks. As of March 31, 2011, the Bank operated 82 branches in Florida, North Carolina and South Carolina. On July 16, 2010, the Bank acquired approximately $1.2 billion of assets and assumed approximately $960.1 million of deposits of three banks from the federal deposit insurance corporation (FDIC): First National Bank of the South in Spartanburg, South Carolina, Metro Bank of Dade County in Miami, Florida and Turnberry Bank in Aventura, Florida. On September 30, 2010 and January 28, 2011, the Bank consummated controlling investments in TIB Financial and Capital Bank Corp., respectively. The Bank�� products and services included commercial bank business, consumer bank business, Mortgage Banking, and Private Banking, Trust and Investment Management. In October 2012, it acquired Southern Community Financial Corp.
Lending activities
As of March 31, 2011, the Bank�� loans included: Real estate mortgage loans, Commercial and agricultural loans and Home equity loans. Real estate mortgage loans include: Commercial, Residential, and Construction and vacant land. As of March 31, 2011, covered loans were $656.6 million, representing 22.3% of its loan portfolio. As of March 31, 2011, non-covered loans were $2.3 billion, representing 77.6% of its loan portfolio. As of March 31, 2011, loans related to real estate totaled $2.6 billion (or 87% of the Bank�� total loan portfolio). At March 31, 2011, commercial real estate loans in all regions totaled $1.8 billion.
Investment activities
Investment securities represent a major portion of the Bank�� assets. As of March 31, 2011, the Bank�� investment securities included mortgage backed securities, United States government agen! cies, states and political subdivisions, corporate bonds, equity, collateralized debt obligations and foreign government. Of the securities in the portfolio, 94% were rated AAA, and 97% were rated A or higher.
Sources of Funds
As of March 31, 2011, the Bank�� deposits included Non-interest demand deposit accounts, Interest Bearing demand deposit accounts, Savings and Money Market. It also included Customer Time Deposits and Wholesale Time Deposits. At March 31, 2011, total deposits were $3.5 billion of which $3.4 billion (or 97%) were non-brokered deposits and $94.4 million (or 3%) were brokered deposits. At March 31, 2011, the Bank�� core deposits (which are all deposits other than time deposits) consisted of $463.2 million of non-interest checking, $430.7 million of negotiable order of withdrawal accounts, $157.5 million of savings accounts and $456.2 million of money market deposits.
The Bank competes with Bank of America, Wells Fargo, BB&T, First Citizens, Royal Bank of Canada, SunTrust, Regions, FNB United Corp., Toronto-Dominion, Synovus, First Financial, SCBT, JPMorgan Chase, Citigroup, EverBank, Fifth Third Bancorp, First Horizon, Pinnacle Financial, First South and U.S. Bancorp.
Advisors' Opinion:- [By Tim Melvin]
The year ahead should be a great one for the smaller bank stocks. Larger regionals like Huntington Bancorp (HBAN) and Capital Ban Financial (CBF) have made it clear they intend to grow by acquisition in the years ahead. Banks like First Merit (FMER) and First Merchants (FRME) have done deals in the past year and are open to doing more to increase their market share and footprints. This should be the year the floodgates open and we see the first wave of merger activity in small banks.
Top 5 Stocks To Invest In 2014: Rockwell Medical Technologies Inc.(RMTI)
Rockwell Medical Technologies, Inc. manufactures, sells, and distributes hemodialysis concentrate solutions and dialysis kits primarily in the United States, Latin America, Asia, and Europe. The company?s hemodialysis product duplicates kidney function in patients with failing kidneys, known as end stage renal disease, an advanced stage of chronic kidney disease; and dialysis solutions are used to maintain life, remove toxins, and replace nutrients in the dialysis patient?s bloodstream. Its products include Renal Pure and CitraPure liquid acid concentrate, Dri-Sate dry acid concentrate and mixing systems, RenalPure powder bicarbonate concentrate, and SteriLyte liquid bicarbonate concentrates; and various ancillary products comprising blood tubing, fistula needles, specialized custom kits, dressings, cleaning agents, filtration salts, and other supplies. The company also has a license to manufacture and sell soluble ferric pyrophosphate (SFP), a Phase III clinical trial p roduct to improve the treatment of dialysis patients with iron deficiency. Rockwell Medical Technologies sells its products to domestic hemodialysis providers through direct sales people and independent sales representation companies, as well as through independent sales agents and distributors internationally. The company was founded in 1995 and is based in Wixom, Michigan.
Advisors' Opinion:- [By Roberto Pedone]
Rockwell Medical (RMTI) manufactures hemodialysis concentrate solutions and dialysis kits, and it sells, distributes and delivers these and other ancillary hemodialysis products primarily to hemodialysis providers in the U.S. and internationally. This stock closed up 5.3% to $5.17 in Tuesday's trading session.
Tuesday's Range: $4.89-$5.25
52-Week Range: $3.16-$8.59
Tuesday's Volume: 1.15 million
Three-Month Average Volume: 1.26 millionFrom a technical perspective, RMTI bounced sharply higher here right above some near-term support levels at $4.81 to $4.65 with decent upside volume. This move is quickly pushing shares of RMTI within range of triggering a major breakout trade. That trade will hit if RMTI manages to take out its 200-day moving average at $5.24 and then once it clears more near-term resistance at $5.94 with high volume.
Traders should now look for long-biased trades in RMTI as long as it's trending above some key near-term support levels at $4.81 to $4.65 and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.26 million shares. If that breakout triggers soon, then RMTI will set up to re-test or possibly take out its next major overhead resistance levels at $8 to $8.50.
- [By John Udovich]
Small cap dialysis stock Rockwell Medical Inc (NASDAQ: RMTI) looks set to decline when the market opens after Brean Capital initiated coverage with a sell rating and a price target of $4.00, meaning it might be time to take a closer look at what is going on with the stock along with�the performance of large cap dialysis stocks DaVita Healthcare Partners (NYSE: DVA)�and Fresenius Medical Care (NYSE: FMS) along with small cap dialysis stocks NxStage Medical, Inc (NASDAQ: NXTM).�
- [By Jake L'Ecuyer]
Rockwell Medical (NASDAQ: RMTI) was also down, falling 19.90 percent to $10.80 after Brean Capital initiated the company at a Sell rating and a $4 price target.
No comments:
Post a Comment